ABB Robotics Partners with NVIDIA to Deliver Industrial-Grade Physical AI at Scale
9.3.2026 14:00:00 EET | Business Wire | Press release
ABB Robotics announced today it is integrating NVIDIA Omniverse libraries into ABB Robotics’ RobotStudio® to help manufacturers deploy physical AI in real world robotics applications.
“Today, using NVIDIA accelerated computing and simulation technologies, we have removed the last barriers to making industrial and physical AI a reality at a global scale by closing the sim-to-real gap,” said Marc Segura, President of ABB Robotics. “For more than 50 years, ABB Robotics has led the evolution of intelligent industrial automation, from pioneering the first generation of fully electric industrial robots to advancing digital twin simulation through RobotStudio® and shaping a new area of autonomous and versatile mobile robots. Today’s announcement with NVIDIA brings physical AI to industry at scale.”
The collaboration focuses on combining ABB Robotics’ software programming, design and simulation suite, RobotStudio, with the physically accurate simulation power of NVIDIA Omniverse libraries to close technology's long-standing 'sim-to-real’ gap. Developers can simulate robots in digital twins and generate synthetic data to train their physical AI models, enabling businesses of all types and sizes to deploy AI-driven robotics for various industrial workflows.
Called RobotStudio HyperReality, the resulting physically accurate simulations and foundation models are endlessly optimized with real-world data feedback continuously improving the system. These models can be used to train any number of ABB robots, anywhere in the world, with the reliability and accuracy demanded by industry.
“The industrial sector needs physically accurate simulation to bridge the gap between virtual training and the real-world deployment of AI-driven robotics at scale,” said Deepu Talla, vice president of robotics and edge AI at NVIDIA. “Integrating NVIDIA Omniverse libraries into RobotStudio brings advanced simulation and accelerated computing to ABB Robotics’ unique virtual controller technology, accelerating how manufacturers of all sizes bring complex products to market.”
Closing the ‘sim-to-real’ gap
The long-standing deficit between simulation accuracy and real-world lighting, materials and environments is known as the ‘sim-to-real’ gap. For decades, this gap has limited the ability of manufacturers to design and develop advanced manufacturing processes in the virtual world.
By integrating NVIDIA Omniverse libraries into RobotStudio, ABB Robotics will deliver unprecedented robotics simulation and synthetic data generation capabilities that will allow intelligent robots to bridge this gap with up to 99 percent accuracy. ABB is the only robot manufacturer with a virtual controller running the same firmware as the hardware, ensuring near‑perfect correlation between simulation and real‑world performance. Combined with ABB Robotics’ Absolute Accuracy technology, which reduces positioning errors from 8–15 mm to around 0.5 mm, ABB delivers unmatched precision in both virtual and physical environments, making it suited to high-precision industrial-grade applications.
This innovation enables manufacturers to design, test, and optimize production lines virtually, cutting setup and commissioning times by up to 80 percent, reducing costs by up to 40 percent by eliminating the need for physical prototypes, and accelerating time-to-market for complex products such as consumer electronics by 50 percent1.
ABB Robotics is also assessing the potential to integrate the NVIDIA Jetson edge computing platform into its Omnicore controller to achieve real-time AI inference at the edge for its extensive robot portfolio. Today’s announcement builds upon ABB Robotics’ long-standing work with NVIDIA, including the previous integration of NVIDIA Jetson into ABB Robotics’ VSLAM autonomous mobile robots as well as the development of gigawatt-scale AI data centers.
Real-world applications, today
RobotStudio HyperReality will serve industrial clients at any scale, across a breadth of industries and applications, with select customers already testing its capabilities ahead of a full release to ABB Robotics’ 60,000 RobotStudio customers worldwide in the second half of 2026.
Foxconn, the world’s largest electronics contract manufacturer, is piloting the first joint use case in consumer electronics assembly. Automating the assembly of a tiny piece in consumer electronics is challenging, as multiple device variants require different production methods and the delicate metal structure requires precise pick-and-place and assembly control, as well as fine-tuned setup, often demanding additional debugging time and engineering resources. Using RobotStudio HyperReality, Foxconn’s assembly robots are trained virtually, using synthetic data to perfect multiple real-world production processes in various scenarios, before moving them to the production line with 99 percent accuracy. By optimizing production lines virtually, Foxconn will reduce set-up times and costs by eliminating physical training and tests, and accelerate time-to-market for consumer electronics.
“Precision is everything in consumer electronics manufacturing and until now, this level of accuracy and fidelity just wasn’t possible in simulation and digital twins,” said Dr. Zhe Shi, Chief Digital Officer of Foxconn. “We’re incredibly excited by the potential of ABB Robotics and NVIDIA’s collaboration, which enables parallel engineering for better designs, faster production ramp‑up and greater product evolution through advanced AI inference and understanding.”
WORKR, a California based robotic workforce company that delivers robotic manufacturing solutions to industry, is extending the reach of this technology to small and medium manufacturers across the United States. At NVIDIA GTC 2026 (March 16-19, San Jose, CA), WORKR will demonstrate AI- powered robotic systems built on ABB technology, trained with synthetic data using NVIDIA Omniverse libraries, and deployed without operators needing to know any programming. By combining ABB's industrial grade robotics with its proprietary WorkrCore™ AI platform, the company is helping manufacturers address critical labor shortages with its robotic workforce that can learn new tasks in minutes and be operated by anyone.
"This collaboration is about making industrial AI deployable today,” said Ken Macken, CEO & Founder of WORKR. “Together with ABB and NVIDIA, we're proving that advanced automation can work for manufacturers of any size."
1. ABB Robotics analysis
ABB Robotics as one of the world’s leading robotics companies, is the only company with a comprehensive and integrated AI-powered portfolio covering robots, cobots and Autonomous Mobile Robots (AMRs), designed and orchestrated by our value-creating software. We help companies of all sizes and sectors - from automotive to electronics and logistics – to outperform by becoming more resilient, flexible and efficient. ABB Robotics is at the forefront of developing and commercializing a new generation of Autonomous Versatile Robotics (AVR), leading a global innovation ecosystem of partners in advancing efficient hardware and intelligent software with industrial performance. The business employs approximately 7,000 people. go.abb/robotics
View source version on businesswire.com: https://www.businesswire.com/news/home/20260309674828/en/
Contacts
Media Relations
Rory Smith
Email: rory.smith@gb.abb.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 12:47:00 EEST | Press release
Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food products. Within this inspiring premise, Good Food Makers confirms itself as one of the main levers f
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 11:16:00 EEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom